Source: GlobalNewswire

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Dragan Grabulovski

CEO Approval Rating

82/100

Araris is a Switzerland-based biotechnology company that researches and develops novel antibody-drug conjugates for the treatment of cancer.

Araris Was acquired by TAIHO PHARMACEUTICAL CO., LTD. for $400M